Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and mendelian randomization study

Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and mendelian randomization study

<p>There is conflicting real-world evidence regarding the risk of breast and bladder cancer associated with sodium glucose cotransporter 2 (SGLT2) inhibitors. We conducted a pharmacovigilance study on SGLT2 inhibitors and breast and bladder cancer using the US FDA Adverse Event Reporting Syste...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autore principale: Bo Xu (233514) (author)
Altri autori: Tianqiao Zhang (22675400) (author), Yechuan He (22052186) (author), Aihua Jiang (3394685) (author), Yinglan Liu (8128521) (author), Zunbo He (19504945) (author), Jiecan Zhou (6517283) (author)
Pubblicazione: 2025
Soggetti:
Medicine
Physiology
Pharmacology
Biotechnology
Sociology
Immunology
Cancer
Biological Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
SGLT2 inhibitors
Aersmine
FAERS
bladder cancer
breast cancer
mendelian randomization
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi